Last Updated : Tuesday, June 16, 2020 11:30:39

Tag Archives: Zydus Cadila

CADILA HEALTH gets USFDA nod to sell medicine to treat blood disorders

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Pankaj Patel led healthcare services and pharma & wellness products manufacturing Zydus Group’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell medicine to treat excess iron

(ZYDUS) CADILA HEALTH gets USFDA nod to sell medicine to treat HIV

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led healthcare services providing and pharmaceutical as well as wellness products manufacturing group Zydus Cadila’s flagship company Cadila Healthcare Ltd said of having got USFDA (US Food & Drugs Administration) nod to sell

CADILA HEALTH got USFDA nod to sell medicine, to treat low blood-pressure

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory filing as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical products, healthcare and wellness products manufacturing Indian Company Dr Pankaj Patel led Zydus Group’s pharma products manufacturing arm Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to sell medicines

CADILA HEALTH gets USFDA nod to sell blood-sugar control tablets for diabetics

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical, wellness and healthcare sector Indian company Dr Pankaj Patel owned Zydus Group’s Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to sell blood-sugar control tablets as administered to diabetic

(ZYDUS) CADILA HEALTH explores biological route to treat Corona Virus

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr. Pankaj Patel led healthcare, pharmaceutical and wellness product manufacturing Zydus Cadila Group’s – pharma arm Cadila Healthcare Ltd said of exploring biological route to treat corona virus, which is based on the data and observations

ZYDUS CADILA gets USFDA nod to sell tablets to treat Diabetis, Heart Diseases

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical, healthcare & wellness enterprise – Dr Pankaj Patel led Zydus Cadila Group’s healthcare arm – Cadila Healthcare Ltd said of having got USFDA (US Food and Drugs Administration) nod to market tablets in dosage value

CADILA HEALTH gets USFDA nod to sell tablets to treat cancer conditions

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Cadila Group’s – Cadila Healthcare Ltd said of having got final approval from USFDA (US Food and Drugs Administration) for tablet to treat several types of cancer. In a press-release titled,

CADILA HEALTH gets USFDA nod to market tablets to treat Parkinson’s disease

AHMEDABAD / MUMBAI / RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) got USFDA (US Food and Drugs Administration) nod to market tablet to treat Parkinson’s disease or Parkinson’s like symptoms. In a company press-release titled, “Zydus receives

ZYDUS CADILA’s Diabetic treatment drug gets nod from Indian Drug Regulator

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Group company Cadila Healthcare Ltd said of having got approval from Drug Controller General of India (DCDI) for Saroglitazar Magnesium for treatment of diabetes. To read more, please CLICK here. Long Read

CADILA inks licensing agreement to market Anemia treatment in China

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharmaceutical products manufacturing company Cadila Healthcare Ltd said of having entered into licensing agreement with China Medical System Holdings for marketing anemia treatment in Greater China. The press-release titled, “Zydus and China Medical System Holdings enter

ZYDUS CADILA gets USFDA nod to market affordable anti-diabetic tablet

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel owned Zydus Group’s pharma arm Cadila Healthcare Ltd said of having got nod from USFDA (US Food and Drugs Administration) to market an affordable anti-diabetic tablet Vinglyn, which is now one of the most

CADILA HEALTH (ZYDUS) gets USFDA nod to market medicine for cardiac cure & skin treatment

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel lead Zydus Cadila Group) said of having got nod from USFDA (US Food & Drugs Administration) to market medicines to cure cardiac problems and skin-treatment. In a press-release as submitted by

Cadila gets USFDA nod to market blood-pressure, heart disease treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press-release submitted to the Indian Stock Exchanges, Ahmedabad headquartered pharma major Cadila Healthcare Ltd (Dr. Pankaj Patel led Zydus Cadila Group) said of having got approval from US FDA (Food & Drugs Administration) to market tablets to treat blood-pressure and heart disease. The press-statement, as addressed by

Zydus announces patient enrollment in clinical trials of Saroglitazar

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory filing submitted to the Indian Stock Exchanges, Ahmedabad headquartered Indian Pharma major Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Group) said of having enrolled patient(s) in evidences VII phase 2 clinical trial of Saroglitazar Magnesium. The company-statement submitted to the Indian Bourses, titled – “Zydus

USFDA classifies Zydus Cadila’s Moraiya unit vide Official Action Initiated

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory updates submitted to the Indian Stock Exchanges, Ahmedabad headquartered Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of its Moraiya facility categorized vide Official Action Initiated by US FDA (Food & Drugs Administration). The statement submitted by the company to the Indian Bourses

Zydus announces completion of Phase III trial of Saroglitazar Magnesium

AHMEDABAB | MUMBAI | RAJKOT – In a press release submitted to the Indian Stock Exchanges, Ahmedabad headquartered Indian pharma major Cadila Healthcare Ltd (Dr Pankaj Patel led Zydus Cadila Group) said of having completed Phase III trials of Saroglitazar Magnesium in Type 2 Diabetes Mellitus. The press release titled, “Zydus Announces Completion of Phase

Do NOT follow this link or you will be banned from the site!